Angel Tang Nakamura | People

Angel Tang Nakamura's practice focuses on the management of complex, multi-party litigation, including class actions and multi-district litigation. Her clients include pharmaceutical, medical device, and consumer product manufacturers. She has served as national counsel in numerous mass torts proceedings, where she supervised various aspects of litigation planning and strategy. Her work over the years has included pre-trial assessments and consultations, working with state and federal regulators, crisis management and recalls, discovery strategy and management, expert witness development, and end game strategy.

Angel also represents clients in data breach and privacy litigation, including in class action lawsuits seeking to assert a private right of action under the California Consumer Privacy Act (CCPA).

Angel serves on the firm's Hiring and Pro Bono Committees. Her pro bono commitments focus on assisting foster care families through the adoptions process. Angel is also a focused on implementing programs to enhance the well-being and mental health of legal practitioners and is a member of the firm-wide Wellness Committee.

Focus Areas

Experience

Global container shipping company in putative class action by residents and businesses alleging they were harmed by oil spill off the coast of Huntington Beach, California.
Pharmaceutical company in product liability litigation and government investigations concerning contaminated heparin products.
Medical device company in product liability litigation involving vaginal mesh products.
Major pharmaceutical company as national counsel in litigation and global settlement of cases brought by patients alleging injuries as a result of use of diet drugs.
Major tobacco company in product liability litigation (including in a national MDL) brought by smokers alleging cancer-related injuries.

Major pharmaceutical company in litigation (including in a national MDL) alleging fraudulent marketing and improper distribution of opioids for chronic pain.
Major pharmaceutical company in product liability litigation (including in a national MDL) involving testosterone replacement therapy products.

BP with respect to the Deepwater Horizon Gulf of Mexico oil spill, including on regulatory, litigation, and settlement matters, and in government investigations.
BP with respect to the Alaska Gasline Port Authority v. ExxonMobil corp., et al. matter. Obtained dismissal of a federal antitrust lawsuit alleging that owners of Alaska North Slope natural gas reserves conspired to block plaintiff's ability to construct a US$24 billion pipeline to transport Alaska gas to the lower 48 states. District court granted motion to dismiss the action; appeal filed and then dismissed.
Leading financial institution in litigation relating to residential mortgage backed securitization trusts.
Internet Service Provider in a trade secrets misappropriation action.

Technology company in defending data breach class action related to file transfer software (N.D. Cal. 2023).
Global software company in defending data privacy class action alleging unlawful wiretapping under CIPA (Cal. St. Ct. 2023).
Gilead Sciences Inc. in defending privacy class action relating to program mailers (Cal. St. Ct. 2020).
Tandem Diabetes Care in defending pending data breach class action obtaining dismissal of CCPA claims (S.D. Cal. 2020).
Hospitality reservation processor in obtaining dismissal of class action data breach claims involving alleged theft of payment card information. Smith v. Sabre Corporation (C.D. Cal. 2018).

Brooks Brothers in obtaining dismissal of class action data breach claims involving alleged theft of payment card information. Ables v. Brooks Brothers Group (C.D. Cal. 2018).